Eurostar R&D grant

March 2, 2020
Onera and Verhaert receive Eurostar R&D grant to modernize sleep diagnostic and monitoring technology.

Onera and its partner Verhaert were awarded a Eurostar grant to develop a patch-based chest-attached sleep diagnostic system designed to improve the way sleep studies are performed.

The partnership’s mutual goal is to improve the way a variety of sleep disorders are diagnosed and monitored. The collaborative project DISPATCH will be a combination of Onera’s wireless analytical patch that attaches to the chest like a band-aid, and an upcoming bedside base station designed by Verhaert.

Eurostars is the most extensive international funding program for SMEs wishing to collaborate on R&D projects that create innovative products, processes, or services for commercialization.

‍

Address
Europe
Eindhoven, The Netherlands
US
Palo Alto, CA, USA
Contact
info@onerahealth.com
Follow us on
LinkedIn
The Onera STS I is CE marked (MDD 93/42/eec)
510(k) FDA
Cleared
 © 2023 Onera Technologies B.V.
Terms and conditionsPrivacy policyCookie PolicyDisclaimerCookie preferences
FDA 510k cleared and CE-marked refers to the Onera Sleep Test System, which is a Class IIa medical device. Onera STS includes the Onera STS I System, which is CE marked in Europe, and the Onera STS System, which was cleared the the Food and Drug Administration for use in the United States.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept